Search for: "Amgen Inc" Results 21 - 40 of 695
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Dec 2017, 9:11 pm by Patent Docs
Amgen Inc., the Supreme Court handed down its interpretation of the Biologics Price Competition and Innovation Act ("BPCIA") for the approval of biosimilar drugs. [read post]
19 Nov 2017, 9:05 pm by Patent Docs
Noonan -- Last month, the Federal Circuit rendered a decision in Amgen Inc. v. [read post]
11 Oct 2008, 4:45 am
Noonan -- The Federal Circuit today issued an Order, pursuant to Federal Circuit Rule 36, affirming the District Court's grant of a preliminary injunction in Amgen Inc. v. [read post]
8 May 2019, 12:08 pm by Lawrence B. Ebert
Sandoz prevailed against the appeal of Amgen at the CAFC:Amgen Inc. and Amgen Manufacturing Ltd. [read post]
24 Oct 2007, 7:47 pm
Here's an excerpt from the Wall Street Journal's article, Amgen Earnings Slump, by Andrew Edwards: Amgen Inc.'s third-quarter net income tumbled as the biotechnology company posted... [read post]
7 Feb 2008, 8:48 pm
Del.) granted leave to Amgen Inc. to amend and supplement its reply to ARIAD Pharmaceuticals Inc.'s counterclaims to include new claims of inequitable conduct. [read post]
7 Feb 2012, 2:19 pm by info@thomasjhenrylaw.com
Amgen Inc.'s cancer drug Xgeva is up for review by the FDA's oncologic drugs advisory committee this Wednesday as the manufacturer aims to expand its uses. [read post]
28 Sep 2023, 6:22 am by Warren K. MacRae
Relying on the analysis provided by the Supreme Court’s recent decision, Amgen Inc. v. [read post]
28 Sep 2023, 6:22 am by Warren K. MacRae
Relying on the analysis provided by the Supreme Court’s recent decision, Amgen Inc. v. [read post]
15 Apr 2017, 8:47 pm by Patent Docs
Amgen Inc. case beginning at 4:30 pm (Eastern) on April 26, 2017 at the American University Washington College of Law in Washington, DC. [read post]
3 Oct 2023, 4:15 am by Kirk Hartung
The Supreme Court decided Amgen Inc. v. [read post]
3 Oct 2008, 5:00 am
wsj.online noted: Amgen Inc. said a federal court granted the biotechnology company a permanent injunction prohibiting Roche Holding AG from selling its Mircera anemia treatment in the U.S., while also upholding a jury verdict regarding certain patent-infringement claims.The ruling represents a big victory for Amgen, whose anemia drugs Aranesp and Epogen accounted for more than 40% of its revenue last year. [read post]
10 Sep 2008, 2:41 pm
The LA Times reported: Amgen Inc., the world's largest biotechnology company, was sued by the University of Iowa over claims that the arthritis drug Enbrel and the colon cancer treatment Vectibix are made using a technique patented by the school. [read post]